SUPNNasdaq United States
Market cap
$2.769 B
$47.64 +1.88%
Close of 7 Aug 2026
Revenue
$719.0M
#1727 by revenue
Earnings
-$38.6M
Loss-making
Shares outstanding
58,127,013
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Supernus Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.